• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Insite Vision Inc

IVF:GR

Ticker Delisted

Snapshot for Insite Vision Inc (IVF)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for IVF

No chart data available.
  • IVF:GR
  • 1M
  • 1Y
0.000
Interactive IVF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IVF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1400
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IVF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IVF

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerKamran HosseiniChief Medical Officer
Louis C DrapeauVP/CFOLyle M BowmanVP:Development/Secretary
More Company Profile & Key Executives for IVF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil